Clinical Trials Logo

Clinical Trial Summary

The purpose of this research study is to evaluate the immediate effectiveness of the GFX™ device in reducing the furrows (deep frown lines) between eyebrows (glabellar region).


Clinical Trial Description

The purpose of this research study is to evaluate the acute ability of GFX to reduce glabellar furrowing.

Patients who have presented to the investigator for correction of glabellar furrows, as classified per the Rated Numeric Kinetic Line Scale Score for Facial Wrinkles Secondary to Hyperkinetic Function (Note: Class 1 or Higher)7 (Appendix N) are candidates for this study. All patients must consent to the procedure and agree to complete their post treatment evaluation visit. ;


Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00612378
Study type Interventional
Source Advanced Cosmetic Intervention
Contact
Status Completed
Phase N/A
Start date September 2007
Completion date March 2008

See also
  Status Clinical Trial Phase
Completed NCT01950065 - Effectiveness and Safety Study of the Iovera Device for the Temporary Reduction in the Appearance of Forehead Wrinkles N/A
Completed NCT03799484 - Botulinum Toxin Type A Injection After Topical Anesthesia Versus Petrolatum Ointment Phase 4